Screener
Intellia Therapeutics NTLA Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net proceeds from issuance of common stock through at-the-market offerings | 33,569 | 13,415 |
| Proceeds from options exercised | 16 | - |
| Issuance of shares through employee stock purchase plan | 1,520 | 1,237 |
| Net cash provided by financing activities | 229,685 | 14,652 |
| Net decrease in cash, cash equivalents and restricted cash equivalents | (46,036) | (32,662) |
| Cash, cash equivalents and restricted cash equivalents, beginning of period | 167,568 | 202,787 |
| Cash, cash equivalents and restricted cash equivalents, end of period | $121,532 | $170,125 |
| Reconciliation of cash, cash equivalents and restricted cash equivalents to condensed consolidated balance sheet: |
Item 1. Financial Statements
FAQ
- What is Intellia Therapeutics's financing cash flow?
- Intellia Therapeutics (NTLA) reported financing cash flow of $196.12M in Q2 2026.
- How has Intellia Therapeutics's financing cash flow changed year-over-year?
- Intellia Therapeutics's financing cash flow increased by 1238.5% year-over-year, from $14.65M to $196.12M.
- What is the long-term trend for Intellia Therapeutics's financing cash flow?
- Over 4 years (2021 to 2025), Intellia Therapeutics's financing cash flow has grown at a -35.0% compound annual growth rate (CAGR), from $736.69M to $131.49M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Intellia Therapeutics's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude